Breast care pathway

Breast Ultrasound

From screening to diagnosis to staging to monitoring, GE Healthcare offers solutions across the entire breast care pathway including Invenia ABUS 2.0, designed to detect cancer in dense breast tissue.
Invenia ABUS 2.0
LOGIQ E10 Series
LOGIQ Fortis™

Invenia ABUS 2.0 for dense breasts

Clinical evidence is growing about the effectiveness of ultrasound for finding small, node-negative, invasive cancers that may be missed by mammography1. Patient-friendly Invenia™ ABUS 2.0 is the first FDA-approved ultrasound supplemental screening technology that is specifically designed for detecting cancer in dense breast tissue.

Designed for screening

Improve breast cancer detection by 35.7 percent over mammography alone.2

Remarkable image quality

Look differently at dense breast tissue with advanced interpretation tools

AI Assistant

Helps to detect and characterize breast lesions for clinical confidence

LOGIQ E10 Series Ultrasound

The LOGIQ™ E10 Series helps you make a real difference in the lives of patients with breast disease. The systems’ cSound™ Architecture provides images of excellent detail and contrast resolution for greater diagnostic confidence, while new AI-based workflow tools help increase exam efficiency.

AI decision support

Breast Assistant powered by Koios DS™ harnesses AI for clinical confidence

Advanced breast tools

Label, measure and describe lesions, nodules, and lymph nodes

Compare assistant

Compare a prior ultrasound, mammography, CT or MR image with current images

2D shear wave elastography

Quantiative measure of tissue elasticity shown in color-coded elastograms

LOGIQ Fortis™ Ultrasound

The GE LOGIQ Fortis™ ultrasound is built to help clinicians deliver on the promise of confident care in breast imaging. Small and sleek enough to move to patients throughout your facility and equipped with our most powerful technology, it is GE’s affordable all-in-one solution.

AI decision support

Breast Assistant powered by Koios DS™ harnesses AI for clinical confidence

Auto lesion segmentation

Saves keystrokes and provides consistency when measuring lesions

Measure assistant

Simple steps to assist the user with breast measurements

Breast productivity

Measurement package to make labeling, measuring and describing lesions easy

Personalized breast care with ultrasound

Screening; diagnosis and staging; treatment; and follow-up: Our breast ultrasound offerings feature excellent measurement and decision support tools to help you provide excellent care for your patients wherever they may be on the care pathway.

REFERENCES
  1. 1. Mandelson et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000; 92:1081–1087.
  2. 2. FDA PMA P110006 summary of safety and effectiveness

Have a question? We would love to hear from you.

JB14080XX